Meeting
Plenary Presentations
Abstract Number: 0003
SHM Converge 2025
Background: Hospitalizations related to opioid use disorder (OUD) are rising, creating opportunities to initiate medications for opioid use disorder (MOUD) and connect patients with outpatient resources.1,2 Despite evidence that MOUD reduces morbidity and mortality, most patients fail to receive evidence-based treatment during hospitalization.3-6 Addiction consultation services are becoming the standard of care to address this [...]
Abstract Number: 161
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: There are an estimated 3.5 million people in the United States living with Hepatitis C virus (HCV); 75-85% of those will develop a chronic infection that can result in liver complications. It is crucial to identify positive infections immediately to ensure linkage to a provider and prevent the advancement of HCV. Initial face-to-face contact [...]
Abstract Number: 282
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Chronic hepatitis C virus (HCV) is a leading cause of liver failure and cancer. Half of 3.5 million infected persons in the U.S. know their status, and 43% have access to care. Despite antivirals that make HCV curable, barriers persist including insufficient screening and late diagnosis. Many infected individuals access healthcare but are not [...]
Plenary Presentations
Abstract Number: 0003
SHM Converge 2025
Background: Hospitalizations related to opioid use disorder (OUD) are rising, creating opportunities to initiate medications for opioid use disorder (MOUD) and connect patients with outpatient resources.1,2 Despite evidence that MOUD reduces morbidity and mortality, most patients fail to receive evidence-based treatment during hospitalization.3-6 Addiction consultation services are becoming the standard of care to address this [...]